摘要
目的研究对慢性脑血管功能不全患者行尼莫地平联合川芎嗪治疗的临床效果。方法选取我院确诊的慢性脑血管功能不全患者60例,随机分为实验组和对照组两组,各30例,对照组单纯给予口服尼莫地平进行治疗;实验组在此基础上联合静脉滴注丹参川芎嗪注射液治疗,治疗期1个月,对治疗后两组患者的疗效和不良反应发生情况予以对比分析。结果治疗后实验组总有效率达到96.67%(29/30),高于对照组的73.33%(22/30),两组比较差异具有统计学意义(P<0.05);实验组不良反应发生率为6.67%(2/30),对照组不良反应发生率为10%(3/30),两组比较差异无统计学意义(P>0.05)。结论对慢性脑血管功能不全患者行尼莫地平联合川芎嗪治疗临床疗效显著,安全可靠,临床实用价值高。
Objective Research on chronic cerebral vascular insufifciency patients TMP nimodipine therapy clinical results. Methods A total of 60 patients with chronic cerebrovascular insufifciency were randomly divided into the experimental group and the control group of two groups, each of 30 cases, control group were given oral nimodipine treatment;experimental group on the basis of joint Salvia TMP intravenous injection therapy, treatment of one month, to be analyzed for efficacy and adverse reactions after two groups of occurrence. Results After the experimental treatment group, the total efifciency of 96.67%（29/30）, signiifcantly higher than the 73.33%（22/30）, the difference was statistically signiifcant （P〈0.05）, incidence of adverse reactions in the experimental group 6.67%（2/30）, the occurrence of adverse events in the control group was 10%（3/30）, no signiifcant difference （P〉0.05） groups. Conclusion Chronic cerebral vascular insufifciency patients nimodipine TMP clinical effect is signiifcant, safe, reliable, high clinical value.
出处
《中国继续医学教育》
2015年第24期152-153,共2页
China Continuing Medical Education
关键词
尼莫地平
川芎嗪
脑血管功能不全
疗效对比
Nimodipine
TMP
Cerebral vascular insufficiency
Comparative efifcacy
